Literature DB >> 17267914

Huntington's disease--making connections.

J Timothy Greenamyre1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17267914     DOI: 10.1056/NEJMcibr067022

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  The right to ignore genetic status of late onset genetic disease in the genomic era; Prenatal testing for Huntington disease as a paradigm.

Authors:  A Erez; K Plunkett; V R Sutton; A L McGuire
Journal:  Am J Med Genet A       Date:  2010-07       Impact factor: 2.802

Review 2.  The role of mitochondria in neurodegenerative diseases.

Authors:  Massimiliano Filosto; Mauro Scarpelli; Maria Sofia Cotelli; Valentina Vielmi; Alice Todeschini; Valeria Gregorelli; Paola Tonin; Giuliano Tomelleri; Alessandro Padovani
Journal:  J Neurol       Date:  2011-05-22       Impact factor: 4.849

Review 3.  PGC-1α at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond.

Authors:  Taiji Tsunemi; Albert R La Spada
Journal:  Prog Neurobiol       Date:  2011-11-09       Impact factor: 11.685

Review 4.  The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.

Authors:  Youngnam N Jin; Gail V W Johnson
Journal:  J Bioenerg Biomembr       Date:  2010-06       Impact factor: 2.945

5.  PGC-1α rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function.

Authors:  Taiji Tsunemi; Travis D Ashe; Bradley E Morrison; Kathryn R Soriano; Jonathan Au; Ruben A Vázquez Roque; Eduardo R Lazarowski; Vincent A Damian; Eliezer Masliah; Albert R La Spada
Journal:  Sci Transl Med       Date:  2012-07-11       Impact factor: 17.956

6.  A neurotoxic phosphoform of Elk-1 associates with inclusions from multiple neurodegenerative diseases.

Authors:  Anup Sharma; Linda M Callahan; Jai-Yoon Sul; Tae Kyung Kim; Lindy Barrett; Minsun Kim; James M Powers; Howard Federoff; James Eberwine
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

Review 7.  Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease.

Authors:  Rodrigo A Quintanilla; Gail V W Johnson
Journal:  Brain Res Bull       Date:  2009-07-19       Impact factor: 4.077

8.  Tissue-specific expression of dentin sialophosphoprotein (DSPP) and its polymorphisms in mouse tissues.

Authors:  Guohua Yuan; Yinghua Wang; Jelica Gluhak-Heinrich; Guobin Yang; Lei Chen; Tong Li; Li-An Wu; Zhi Chen; Mary MacDougall; Shuo Chen
Journal:  Cell Biol Int       Date:  2009-05-18       Impact factor: 3.612

Review 9.  Huntington disease models and human neuropathology: similarities and differences.

Authors:  Jean Paul G Vonsattel
Journal:  Acta Neuropathol       Date:  2007-11-03       Impact factor: 17.088

10.  Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression.

Authors:  Fanny Mochel; Perrine Charles; François Seguin; Julie Barritault; Christiane Coussieu; Laurence Perin; Yves Le Bouc; Christiane Gervais; Guislaine Carcelain; Anne Vassault; Josué Feingold; Daniel Rabier; Alexandra Durr
Journal:  PLoS One       Date:  2007-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.